Pearl Raises Series A

Pearl Therapeutics Inc., a Redwood City, Calif.-based drug developer focused on respiratory disorders, has raised $15.5 million in first-round funding. New Leaf Partners and Clarus Ventures co-led the deal, with 5AM Ventures also participating. Pearl Therapeutics was co-founded by two former members of Nektar's corporate and product development organizations.